Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1493337

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1493337

U.S. ENT Devices Market Size, Share & Trends Analysis Report By Product (Hearing Aids, Hearing Implants, Diagnostic ENT Devices, Surgical ENT Devices, Nasal Splints), By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 80 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 3950
Printable PDF (5-User License)
USD 4950
Printable PDF (Enterprise License)
USD 6950

Add to Cart

U.S. ENT Devices Market Growth & Trends:

The U.S. ENT devices market size is anticipated to reach USD 11.5 billion by 2030 and is projected to grow at a CAGR of 4.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of ENT disorders, technological advancements in medical devices, rising healthcare expenditure, and growing awareness among patients about available treatment options are driving market growth. The market includes a wide array of products categorized into segments such as diagnostic devices (endoscopes, audiometers), surgical devices (powered surgical instruments, handheld instruments), hearing aids, implantable hearing devices, voice prosthesis devices, and others.

The aging population in the U.S. is another significant factor contributing to the market growth. As individuals age, they are more prone to developing age-related hearing loss, balance disorders, and other ENT conditions that require medical intervention. The increasing geriatric population has led to a higher demand for hearing aids, amplification devices, and other ENT solutions tailored to meet the specific needs of older patients.

The advancement of technology, particularly the widespread adoption of artificial intelligence (AI) and machine learning (ML), along with continuous innovations in auditory products, is playing a significant role in propelling market growth across various industries. These technological advancements are reshaping how businesses operate, enhancing efficiency, productivity, and overall performance. For instance, in February 2023, Oticon Medical A/S announced new Polaris R processing chip enhancements. This updated chip incorporates an onboard Deep Neural Network for a novel approach to sound processing wind stabilizer.

U.S. ENT Devices Market Report Highlights:

  • The surgical ENT devices segment led the market with the largest revenue share of 30.3% in 2023. The shift towards minimally invasive procedures in ENT surgeries has propelled the demand for innovative surgical devices that offer improved patient outcomes and reduced recovery times
  • The hearing implants segment is anticipated to grow at the fastest CAGR during the forecast period, owing to therising awareness about cochlear implants and the increasing prevalence of hearing loss
Product Code: GVR-4-68040-283-9

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. ENT Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. ENT Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. ENT Devices Market: Product Estimates & Trend Analysis

  • 4.1. Form Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. ENT Devices Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Diagnostic ENT Devices
      • 4.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.2. Rigid Endoscopes
      • 4.4.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.2.2. Sinusscopes
      • 4.4.1.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.2.3. Otoscopes
      • 4.4.1.2.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.2.4. Laryngoscopes
      • 4.4.1.2.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.3. Flexible Endoscopes
      • 4.4.1.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.3.2. Bronchoscopes
      • 4.4.1.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.3.3. Laryngoscopes
      • 4.4.1.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.3.4. Nasopharyngoscopes
      • 4.4.1.3.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.4. Robot Assisted Endoscopes
      • 4.4.1.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.5. Hearing Screening Device Endoscopes
      • 4.4.1.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Surgical ENT Devices
      • 4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.2. Radiofrequency Handpieces
      • 4.4.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.3. Otological Drill Burrs
      • 4.4.2.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.4. ENT Hand Instruments
      • 4.4.2.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.5. Sinus Dilation Devices
      • 4.4.2.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.6. Nasal Packing Devices
      • 4.4.2.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.7. Others
      • 4.4.2.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Hearing Aids
      • 4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. Hearing Implants
      • 4.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.5. Nasal Splints
      • 4.4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. U.S. ENT Devices Market: Region Estimates & Trend Analysis

  • 5.1. Regional Market Share, 2023 & 2030
  • 5.2. U.S. ENT Devices Market by Region Outlook
  • 5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 5.3.1. West
      • 5.3.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.2. Midwest
      • 5.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.3. Northeast
      • 5.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.4. Southwest
      • 5.3.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.5. Southeast
      • 5.3.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company heat map analysis, 2023
  • 6.4. Company Profiles
    • 6.4.1. Ambu A/S.
      • 6.4.1.1. Company overview
      • 6.4.1.2. Financial performance
      • 6.4.1.3. Product benchmarking
      • 6.4.1.4. Strategic initiatives
    • 6.4.2. Cochlear Ltd.
      • 6.4.2.1. Company overview
      • 6.4.2.2. Financial performance
      • 6.4.2.3. Product benchmarking
      • 6.4.2.4. Strategic initiatives
    • 6.4.3. Demant A/S
      • 6.4.3.1. Company overview
      • 6.4.3.2. Financial performance
      • 6.4.3.3. Product benchmarking
      • 6.4.3.4. Strategic initiatives
    • 6.4.4. GN Store Nord A/S
      • 6.4.4.1. Company overview
      • 6.4.4.2. Financial performance
      • 6.4.4.3. Product benchmarking
      • 6.4.4.4. Strategic initiatives
    • 6.4.5. KARL STORZ SE & Co. KG
      • 6.4.5.1. Company overview
      • 6.4.5.2. Financial performance
      • 6.4.5.3. Product benchmarking
      • 6.4.5.4. Strategic initiatives
    • 6.4.6. Olympus Corporation
      • 6.4.6.1. Company overview
      • 6.4.6.2. Financial performance
      • 6.4.6.3. Product benchmarking
      • 6.4.6.4. Strategic initiatives
    • 6.4.7. PENTAX Medical
      • 6.4.7.1. Company overview
      • 6.4.7.2. Financial performance
      • 6.4.7.3. Product benchmarking
      • 6.4.7.4. Strategic initiatives
    • 6.4.8. RION Co., Ltd.
      • 6.4.8.1. Company overview
      • 6.4.8.2. Financial performance
      • 6.4.8.3. Product benchmarking
      • 6.4.8.4. Strategic initiatives
    • 6.4.9. Sonova
      • 6.4.9.1. Company overview
      • 6.4.9.2. Financial performance
      • 6.4.9.3. Product benchmarking
      • 6.4.9.4. Strategic initiatives
    • 6.4.10. Starkey Laboratories, Inc.
      • 6.4.10.1. Company overview
      • 6.4.10.2. Financial performance
      • 6.4.10.3. Product benchmarking
      • 6.4.10.4. Strategic initiatives
    • 6.4.11. Stryker
      • 6.4.11.1. Company overview
      • 6.4.11.2. Financial performance
      • 6.4.11.3. Product benchmarking
      • 6.4.11.4. Strategic initiatives
    • 6.4.12. Nico Corporation
      • 6.4.12.1. Company overview
      • 6.4.12.2. Financial performance
      • 6.4.12.3. Product benchmarking
      • 6.4.12.4. Strategic initiatives
    • 6.4.13. Nemera
      • 6.4.13.1. Company overview
      • 6.4.13.2. Financial performance
      • 6.4.13.3. Product benchmarking
      • 6.4.13.4. Strategic initiatives
Product Code: GVR-4-68040-283-9

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. ENT devices market, by product, 2018 - 2030 (USD Million)
  • Table 3 U.S. ENT devices market, by region, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 US ENT devices market: market outlook
  • Fig. 10 US ENT devices competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 U.S. ENT devices market driver impact
  • Fig. 15 U.S. ENT devices market restraint impact
  • Fig. 16 U.S. ENT devices market: Product movement analysis
  • Fig. 17 U.S. ENT devices market: Product outlook and key takeaways
  • Fig. 18 Diagnostic ENT devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Rigid endoscopes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Sinuscopes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Otoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Laryngoscopes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Flexible endoscopes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Bronchoscopes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Laryngoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Nasopharyngoscopes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Robot assisted endoscope market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Hearing screening device market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Surgical ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Radiofrequency handpieces market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Otological drill burrs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 ENT hand instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Sinus dilation devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Nasal packing devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Hearing aids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Hearing implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Nasal splints market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 US ENT devices market: Regional movement analysis
  • Fig. 40 US ENT devices market: Regional outlook and key takeaways
  • Fig. 41 West market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!